Short Interest in Ainos, Inc. (OTCMKTS:AIMD) Drops By 48.3%
Short Interest in Ainos, Inc. (OTCMKTS:AIMD) Drops By 48.3%
Ainos, Inc. (OTCMKTS:AIMD – Get Rating) was the recipient of a significant decline in short interest in July. As of July 31st, there was short interest totalling 4,600 shares, a decline of 48.3% from the July 15th total of 8,900 shares. Based on an average daily volume of 111,000 shares, the days-to-cover ratio is presently 0.0 days.
艾諾斯公司（OTCMKTS：AIMD-獲取評級）是七月份短期利益顯著下降的收件人。截至 7 月 31 日，共有 4,600 股短期利息，較 7 月 15 日共 8,900 股股份下降 48.3%。根據每日平均成交量為 111,000 股，日數佔覆蓋率目前為 0.0 天。
Ainos Trading Down 11.5 %
亞諾斯交易下跌 11.5%
Shares of OTCMKTS:AIMD opened at $3.24 on Thursday. Ainos has a fifty-two week low of $2.81 and a fifty-two week high of $3.75. The business has a 50-day moving average of $8.21 and a two-hundred day moving average of $7.51. The company has a quick ratio of 0.47, a current ratio of 0.53 and a debt-to-equity ratio of 3.33.
OTCMK 的股票：AIM 股份在周四開盤 3.24 美元。歐洲國家航空公司的五十二周低點為 2.81 美元，五十二周高點為 3.75 美元。該業務的移動平均線為 50 天，為 8.21 美元，兩百日移動平均線為 7.51 美元。該公司的快速比率為 0.47，流動比率為 0.53，債務與權益比率為 3.33。
Ainos (OTCMKTS:AIMD – Get Rating) last announced its quarterly earnings results on Monday, May 16th. The company reported ($0.15) earnings per share for the quarter. Ainos had a negative return on equity of 40.69% and a negative net margin of 802.35%. The company had revenue of $0.09 million during the quarter.
艾諾斯（OTCMKTS：AIMD-獲取評分）上週一公佈了其季度盈利業績，週一，5 月 16 日。該公司報告了本季度每股盈利（0.15 美元）。艾諾斯的資產回報率為負 40.69%，負淨利潤率為 802.35%。該公司在本季度的收入為 0.09 萬美元。
Ainos Company Profile
艾諾斯公司簡介
Ainos, Inc, a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.
Ainos, Inc 是一家醫療保健公司，致力於開發用於點護理測試的醫療技術，以及針對疾病適應症的安全和新穎的醫療治療。本公司提供 COVID-19 抗原快速檢 test 劑盒及 AINOS 雲端 test 管理應用程式，這是一個雲端 test 管理平台，包括抗原快速檢 test 劑盒、個人應用程式、COVID-19 核酸檢測、揮發性有機化合物點護理 test、極低劑量口腔干擾素 Alpha (基於 IFNNA) 的廣泛治療應用、低劑量口腔干擾素 Alpha 技術開發平台。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on Ainos (AIMD)
- Could Rite Aid Be an Acquisition Target, Again?
- The How And Why of Investing in Oil Stocks
- The How and Why of Investing in Gold Stocks
- Workhorse Group Is Ready To Get Back On The Horse
- A Rounded Bottom In Draftkings, Inc Begins To Reverse Course
- 獲取有關艾諾斯研究報告（AIMD）的免費副本
- 儀式可以幫助再次成為獲取目標嗎？
- 如何以及為什麼投資石油股票
- 投資黃金股票的方法和原因
- 主力集團已準備好回到馬上
- 圓形底部在草稿, 公司開始逆轉課程
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
接收艾諾斯日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件時事通訊接收 Ainos 和相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。